DiscoveRx & SGC Technology Symposium

DiscoveRx & SGC Technology Symposium
Targeting Epigenetics for Cancer Therapy: Recent Breakthroughs to Accelerate Drug Discovery

Date: 17th September 2014
Time: 9:30 am - 5:00 pm
Location: NDM Research Building, University of Oxford, Old Road Campus, Headington, OX3 7FZ

Keynote Presentation
Professor Stefan Knapp, Ph.D., Oxford University and SGC

Speaker List

Steve Rees (AstraZeneca)
Karen Roberts (AstraZeneca)
Andrew Baxter (BioSeek)
Christopher Wellaway (GlaxoSmithKline)
Kilian Huber (Austrian Academy of Sciences)
Niall Igoe (UCL School of Pharmacy)
Davide Gianni (Boehringer Ingelheim RCV GmbH &Co KG)
Joëlle Rüegg (KI Institute)
Katherine Jones (Epinova DPU, GlaxoSmithKline)

Details

Home

Epigenetics is an exciting research field at the frontier of modern biology which has already had considerable impact on our understanding of fundamental mechanisms of human health and disease. Research in this area is advancing rapidly and this symposium aims to bring together basic scientists at the forefront of epigenetics and chromatin biology with experts in relevant new technologies to discuss the latest advances in the field.

Join us for a complimentary symposium and learn from key guest speakers and DiscoveRx specialists about novel and enabling cell based and binding assays, used in the study of targets in oncology, metabolism and inflammation. Registration is free and refreshments will be served.